The Discounted Cash Flow (DCF) valuation of SAGE Therapeutics Inc (SAGE) is (267.38) USD. With the latest stock price at 6.53 USD, the upside of SAGE Therapeutics Inc based on DCF is -4194.7%.
Based on the latest price of 6.53 USD and our DCF valuation, SAGE Therapeutics Inc (SAGE) is a sell. selling SAGE stocks now will result in a potential gain of 4194.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 7.5% | 6.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,226.40) - (154.08) | (267.38) |
| Upside | -18881.0% - -2459.6% | -4194.7% |